The impact of human CES1 genetic variation on enzyme activity assessed by ritalinic acid/methylphenidate ratios-Reference-Cited by-同舟云学术

The impact of human CES1 genetic variation on enzyme activity assessed by ritalinic acid/methylphenidate ratios

Published:2019-04-24 Issue: Volume: Page:
ISSN:1742-7835
Container-title:Basic & Clinical Pharmacology & Toxicology
language:en
Short-container-title:Basic Clin Pharmacol Toxicol

Author:

Stage Claus¹,Dalhoff Kim¹,Rasmussen Henrik Berg²,Schow Guski Louise¹,Thomsen Ragnar³,Bjerre Ditte²,Ferrero‐Miliani Laura²,Busk Madsen Majbritt²,Jürgens Gesche⁴

Affiliation:

1. Department of Clinical Pharmacology Bispebjerg and Frederiksberg University Hospital Copenhagen Denmark

2. Institute of Biological Psychiatry, Mental Health Centre Sct. Hans Copenhagen University Hospital Roskilde Denmark

3. Section of Forensic Chemistry, Department of Forensic Medicine, Faculty of Health and Medical Sciences University of Copenhagen Copenhagen Denmark

4. Clinical Pharmacological Unit Zealand University Hospital Roskilde Denmark

Funder

Strategiske Forskningsråd

Publisher

Wiley

Subject

Pharmacology,Toxicology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bcpt.13212

Reference24 articles.

1. Trends in the consumption of attention deficit hyperactivity disorder medications in Castilla y León (Spain): changes in the consumption pattern following the introduction of extended release methylphenidate;Treceño C;Pharmacoepidemiol Drug Saf.,2012

2. Trends in attention deficit hyperactivity disorder drugs consumption, Israel, 2005–2012;Ponizovsky AM;Pharmacoepidemiol Drug Saf.,2014

3. Patterns of methylphenidate use and assessment of its abuse among the general population and individuals with drug dependence;Frauger E;Eur Addict Res.,2016

4. Methylphenidate is stereoselectively hydrolyzed by human carboxylesterase CES1A1;Sun Z;J Pharmacol Exp Ther.,2004

5. Human carboxylesterase 1A2 expressed from carboxylesterase 1A1 and 1A2 genes is a potent predictor of CPT‐11 cytotoxicity in vitro;Tanimoto K;Pharmacogenet Genomics.,2007

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Regulation of carboxylesterases and its impact on pharmacokinetics and pharmacodynamics: an up-to-date review;Expert Opinion on Drug Metabolism & Toxicology;2024-05-03

2. High-Dose Methylphenidate and Carboxylesterase 1 Genetic Variability in Patients With Attention-Deficit/Hyperactivity Disorder;Journal of Clinical Psychopharmacology;2023-10-17

3. An in vitro evaluation of kratom (Mitragyna speciosa) on the catalytic activity of carboxylesterase 1 (CES1);Chemico-Biological Interactions;2023-10

4. Associations between CES1 variants and dosing and adverse effects in children taking methylphenidate;Frontiers in Pediatrics;2023-01-18

5. The Influence of Structural Variants of the CES1 Gene on the Pharmacokinetics of Enalapril, Presumably Due to Linkage Disequilibrium with the Intronic rs2244613;Genes;2022-11-27